The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Journal club · continued

Journal club: what we got wrong in an earlier session posts 121–126

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

BN
b.nilsenTL225 Jul 2026#121

Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.

The strength of my opinion here exceeds the strength of my evidence.

13 likes 2d
NP
n.petrovTL226 Jul 2026#122

Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then limitations. That order makes critique coherent.

5 likes 2d
SC
so.cardosoTL226 Jul 2026#123
t.batista, post #48: The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I would want the raw data before agreeing with my own summary of it. Go to post

I read post #121 twice before replying, because I had assumed the opposite.

The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.

I am confident about the direction and much less about the magnitude.

0 likes in reply to #48 2d
SD
s.dziedzicTL226 Jul 2026#124
ma.nascimento, post #21: Useful. I had the fact and not the reason, which turns out to be the important half. Go to post

I will take the caveat as seriously as the claim, which is the point of putting it there.

0 likes in reply to #21 2d
AS
a.silvaTL227 Jul 2026 · edited#125

Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.

19 likes 1d
OC
o.cousineauTL3Regular27 Jul 2026#126

Building on post #125 rather than restating it.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

8 likes 23h
Moved from Preprints by s.leclerc. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
KBLKSSJLB+120 132 13k 1d
[2026 update] Journal club: PIONEER 6 as a safety trial
Journal club: PIONEER 6 as a safety trial Writing it up because I had to work it out twice and would rather nobody else did. Bringing a claim rather than a paper, because the claim is the thing circulating.…
PPKAVJFBE+14 18 55k 5mo
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is known about SURMOUNT-OSA in one place,…
CIRCBPMN+47 51 617 16mo
Journal club: SURMOUNT-4 and continuation versus withdrawal
Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on SURMOUNT-4 and continuation…
ZNVDTTBMA+32 36 31k 3mo
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1 rather than a conclusion. I would rather…
MDAWRMJDVR+118 132 12k 15mo

Related topics — sharing the tags number needed to treat, effect size, randomised trial

TopicParticipantsRepliesViewsActivity
Triple agonism: additive, synergistic, or neither?
The question in the title: Triple agonism: additive, synergistic, or neither? I will give what I have already checked below so nobody repeats it. Asking about triple agonism on behalf of the question I keep…
EKEPAKTWJD+71 80 38k 11mo
SURMOUNT-4 and what withdrawal data does and does not tell an individual
SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
NSLMAADKA 4 42k 11mo
Non-inferiority margins: how they are chosen and how they are abused — a second dataset
Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Non-inferiority…
FTJIRHAAP+32 37 574 5mo
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Posting a small dataset on STEP 8. It is…
OLIADSRFDO+18 22 656 13h
Why a preprint's supplementary material is often the best part
Why a preprint's supplementary material is often the best part I have a specific reason for asking rather than idle curiosity, and the context is below. A question about how this site should cite something…
SCTWJSMSH+38 42 863 22mo